$196 Million is the total value of HealthInvest Partners AB's 14 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 6.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PFE | Buy | PFIZER INC | $28,366,000 | +54.4% | 846,000 | +60.2% | 14.49% | +13.9% |
| GILD | Buy | GILEAD SCIENCES INC | $28,134,000 | +132.5% | 240,300 | +94.9% | 14.37% | +71.5% |
| ANTM | Buy | ANTHEM INC | $28,019,000 | +65.4% | 170,700 | +55.6% | 14.31% | +22.0% |
| AET | Buy | AETNA INC NEW | $27,519,000 | +62.6% | 215,900 | +35.9% | 14.06% | +19.9% |
| LPNT | Buy | LIFEPOINT HEALTH INC | $18,123,000 | +43.9% | 208,430 | +21.6% | 9.26% | +6.2% |
| GTS | Buy | TRIPLE-S MGMT CORPcl b | $17,025,000 | +78.9% | 663,496 | +38.6% | 8.70% | +32.0% |
| CRL | Buy | CHARLES RIV LABS INTL INC | $16,904,000 | +47.7% | 240,320 | +66.5% | 8.64% | +9.0% |
| MGLN | Sell | MAGELLAN HEALTH INC | $16,778,000 | -9.1% | 239,442 | -8.1% | 8.57% | -32.9% |
| AIQ | ALLIANCE HEALTHCARE SRVCS IN | $9,804,000 | -15.7% | 524,538 | 0.0% | 5.01% | -37.8% | |
| SURG | Buy | SYNERGETICS USA INC | $1,564,000 | +10.6% | 332,687 | +26.8% | 0.80% | -18.4% |
| CRY | CRYOLIFE INC | $1,015,000 | +8.8% | 90,000 | 0.0% | 0.52% | -19.7% | |
| SSRG | SYMMETRY SURGICAL INC | $990,000 | +19.0% | 113,479 | 0.0% | 0.51% | -12.2% | |
| ICCC | Buy | IMMUCELL CORP | $854,000 | +27.5% | 108,750 | +2.1% | 0.44% | -6.0% |
| BASI | BIOANALYTICAL SYS INC | $644,000 | -0.9% | 320,234 | 0.0% | 0.33% | -26.9% | |
| MR | Exit | MINDRAY MEDICAL INTL LTDspon adr | $0 | – | -435,012 | -100.0% | -8.24% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-07-20
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARLES RIV LABS INTL INC | 17 | Q4 2017 | 12.8% |
| GILEAD SCIENCES INC | 16 | Q4 2022 | 14.5% |
| CARDINAL HEALTH INC | 15 | Q4 2022 | 14.8% |
| IMMUCELL CORP | 15 | Q2 2017 | 1.7% |
| MCKESSON CORP | 14 | Q3 2022 | 14.6% |
| ANTHEM INC | 12 | Q4 2017 | 14.3% |
| TRIPLE-S MGMT CORP | 12 | Q4 2016 | 8.7% |
| LIFEPOINT HOSPITALS INC | 11 | Q2 2016 | 13.3% |
| SUPERNUS PHARMACEUTICALS INC | 10 | Q3 2021 | 15.5% |
| ANIKA THERAPEUTICS INC | 10 | Q4 2017 | 13.0% |
View HealthInvest Partners AB's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVAMED INC | March 03, 2011 | 405,875 | 5.1% |
| THERAGENICS CORP | February 11, 2009 | 3,322,846 | 9.9% |
| BIO IMAGING TECHNOLOGIES INC | January 09, 2009 | 766,425 | 5.3% |
| ALLION HEALTHCARE INC | July 07, 2008 | 887,255 | 4.6% |
| SONIC INNOVATIONS INC | June 26, 2008 | 1,328,201 | 4.9% |
| CANDELA CORP /DE/ | June 06, 2008 | 697,164 | 3.1% |
| INTEGRAMED AMERICA INC | June 02, 2008 | 2,200 | 0.0% |
| AFP IMAGING CORP | February 04, 2008 | 27,520 | 0.2% |
| OPHTHALMIC IMAGING SYSTEMS | December 28, 2007 | 834,440 | 4.9% |
| ANGEION CORP/MN | October 16, 2007 | 196,024 | 4.8% |
View HealthInvest Partners AB's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-25 |
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-10-21 |
| 13F-HR | 2022-07-08 |
| 13F-HR | 2022-05-05 |
| 13F-HR | 2022-01-18 |
| 13F-HR | 2021-11-08 |
| 13F-HR | 2021-08-10 |
| 13F-HR | 2021-04-30 |
View HealthInvest Partners AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.